纳斯达克： -- -- --

最近浏览

实时行情

意见反馈

联合健康

NYSE:UNH 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 振幅：
    每股收益：
成交量

董事会

Stephen J. Hemsley
Stephen J. Hemsley currently works at UnitedHealth Group, Inc., as Chairman & Chief Executive Officer from 2025, Cargill, Inc., as Director, and the University of St. Thomas, as Trustee. Mr. Hemsley received his undergraduate degree from Fordham University.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Stephen J. Hemsley
Stephen J. Hemsley currently works at UnitedHealth Group, Inc., as Chairman & Chief Executive Officer from 2025, Cargill, Inc., as Director, and the University of St. Thomas, as Trustee. Mr. Hemsley received his undergraduate degree from Fordham University.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Michele J. Hooper
Michele J. Hooper is the founder of The Directors Council LLC, founded in 2003, serving as President & Chief Executive Officer since 2011. Current jobs include Independent Director at UnitedHealth Group, Inc. since 2025, Independent Director at United Airlines Holdings, Inc. since 2018, and Director at United Airlines, Inc. Former jobs include President & Chief Executive Officer at Stadtlander Drug Co. from 1998 to 1999, President & Chief Executive Officer at Voyager Expanded Learning LP from 1999 to 2000, Independent Director at PPG Industries, Inc. from 2011 to 2020, Director at The Seagram Co. Ltd., Senior Independent Non-Executive Director at AstraZeneca PLC from 2011 to 2012, Director at Target Corp., Independent Director at WMG Acquisition Corp., Director at TLContact, Inc., Director at Endeavor Health Clinical Operations, Director at Warner Music Group Corp. from 2006 to 2011, Director at National Association of Corporate Directors (Virginia) from 2014 to 2016, Director at The Center for Audit Quality from 2014 to 2016, Vice President-Corporate Planning at Baxter Healthcare Corp., President-International Business Group & VP at Caremark International, Inc. from 1992 to 1998, and President at Baxter Corp. from 1988 to 1992. Education includes undergraduate studies at the University of Pennsylvania and an MBA from The University of Chicago.
Timothy Patrick Flynn
Timothy Patrick Flynn currently works at UnitedHealth Group, Inc., as Independent Director from 2017, Walmart, Inc., as Independent Director from 2012, JPMorgan Chase Bank, NA (New York), as Director, YMCA of Greater New York, as Director-Emeritus, Relativity ODA LLC, as Director, JPMorgan Chase Bank NA (United Kingdom), as Director from 2016, and the University of St. Thomas, as Trustee. Mr. Flynn also formerly worked at KPMG International Cooperative, as Chairman & Chief Executive Officer from 2007 to 2011, KPMG LLP, as Chairman from 2008 to 2010, The Chubb Corp., as Independent Director from 2015 to 2016, Pro-After, Inc., as Director, Miromatrix Medical, Inc., as Director, The Partnership for New York City, Inc., as Director, International Integrated Reporting Council, as Director, Alcoa Corp., as Independent Director from 2016 to 2021, JPMorgan Chase & Co., as Independent Director from 2012 to 2024, Financial Accounting Standards Board, as Trustee, The World Economic Forum USA, Inc., as Member-International Business Council, and Prince of Wales, as Member. Mr. Flynn received his undergraduate degree from the University of St. Thomas.
Frederick William McNabb
Frederick William McNabb is currently Chief Executive Officer at The Force for Good Fund, Co-Chairman at Chief Executives For Corporate Purpose, Inc., Vice Chairman at Nexii Building Solutions, Inc., Chairman at USRowing Foundation, Independent Director at International Business Machines Corp. since 2019, Lead Independent Director at UnitedHealth Group, Inc. since 2018, Director at Axiom Global, Inc. since 2019, Director at OpenAdvisor Technologies, Inc., and Advisor at Venrock Associates since 2023. Former roles include Chairman & Chief Executive Officer at The Vanguard Group, Inc. and Vanguard Advisers, Inc., Chairman at Vanguard Fiduciary Trust Co. from 2017 to 2019, Chairman-Governors Board at Investment Company Institute from 2013 to 2016, Chairman-Elect at Zoo Safari Monorails Corp. from 2014 to 2015, Chairman at multiple Vanguard funds from 2017 to 2018, Chairman at Zoological Society of Philadelphia, Director at Vanguard Group (Ireland) Ltd. in 2012, Director at Kroll LLC, Director at United Way of Greater Philadelphia & Southern New Jersey, Director at Bestinvest (Consultants) Ltd. from 2021 to 2022, Non-Executive Director at Evelyn Partners Investment Services Ltd. from 2021 to 2022, Director at Index Fund Advisors Ltd. from 2021 to 2022, and Non-Executive Director at Evelyn Partners Group Ltd. from 2021 to 2022. Education includes undergraduate studies at Dartmouth College and an MBA from The Wharton School of the University of Pennsylvania.
Valerie C. Montgomery Rice
Valerie C. Montgomery Rice currently serves as Independent Director at UnitedHealth Group, Inc. since 2017 and Director at The Nemours Foundation since 2016. Other current roles include Director positions at CARE USA, Grady Health System, Inc., H. Lee Moffitt Cancer Center & Research Institute, Inc., Metro Atlanta Chamber of Commerce, The Josiah Macy, Jr. Foundation, Chris Andersen Roofing & Erecting Co., Inc., Westside Future Fund, Inc., Kaiser Permanente School of Medicine, Wellpath Holdings, Inc., and Council Member at National Institutes of Health and National Center for Advancing Translational Sciences. Additional current roles include Independent Director at Georgia Power Co., Trustee at The Woodruff Arts Center and Georgia Research Alliance, Inc., Member at National Academy of Medicine (United States), Member-Deans Council at The Association of American Medical Colleges, and Member at Horatio Alger Association of US. Former positions include President, Chief Executive Officer & Dean at Morehouse School of Medicine from 2014 to 2021, Independent Director at Chrome Holding Co. from 2021 to 2024, Director at Center for Women's Health from 2005 to 2011, Senior Vice President-Health Affairs at Meharry Medical College from 2006 to 2009, and Director at Headspace, Inc.Education includes undergraduate studies at Georgia Institute of Technology and a doctorate from Harvard Medical School.
John H. Noseworthy
John H. Noseworthy currently works at Aegis Venture Partners LLC, as Chairman from 2024, UnitedHealth Group, Inc., as Independent Director from 2019, AlixPartners Holdings LLP (New York), as Director, The MITRE Corp., as Trustee from 2020, Twin Cities Public Television, Inc., as Member, and Mayo Clinic College of Medicine & Science, as Professor from 1992. Dr. Noseworthy also formerly worked at The Mayo Clinic (Old), as President, Chief Executive Officer & Trustee, Mayo Clinic, as President, Chief Executive Officer & Trustee from 2009 to 2018, Mayo Clinic (Treasury Services), as President & Chief Executive Officer, Merck & Co., Inc., as Independent Director, The World Economic Forum USA, Inc., as Governor from 2012 to 2018, and American Academy of Neurology, as Chief Editor from 2007 to 2009. Dr. Noseworthy received his undergraduate degree and doctorate degree from Dalhousie University.
Paul R. Garcia
Paul R. Garcia currently serves as Independent Director at Deluxe Corp. since 2020, Independent Director at UnitedHealth Group, Inc. since 2021, Director at Truist Bank since 2019, Director at Payment Alliance International, Inc., Director at Atlanta Symphony Orchestra, Director at City Club of Greenville, Director at M & A Ventures LLC, Independent Director at Repay Holdings Corp. since 2019, Trustee at Pace Academy, Inc., and Senior Advisor at Further Global Capital Management LP. Former roles include Chairman, President, CEO, Secretary & Treasurer at Sadhana Equity Investment, Inc. in 2009; President & Chief Executive Officer at DolEx Dollar Express, Inc.; President & Chief Executive Officer at Productivity Point International Ltd. from 1997 to 1998; Chief Executive Officer at NDC e-Commerce from 1999 to 2001; Chief Executive Officer at First Financial Bank (Cincinnati, Ohio) from 1982 to 1995; President & Chief Executive Officer at National Bancard Corp. from 1982 to 1995; Chairman at Global Payments, Inc. from 2013 to 2014; Independent Director at SunTrust Banks, Inc. from 2014 to 2019; Independent Director at West Technology Group LLC from 2013 to 2017; Independent Director at The Dun & Bradstreet Corp. from 2012 to 2019; Director at Verso Technologies, Inc.; Director at Firethorn Holdings LLC; Director at The Woodruff Arts Center; Director at Mastercard International, Inc.; Director at Metro Atlanta Chamber of Commerce; Director at The Electronic Transactions Association; Director at Dun & Bradstreet Ltd.; Director at Truist, Inc.; Director at West Corp., Inc. from 2013 to 2017; Independent Director at Truist Financial Corp. from 2019 to 2021; President, Secretary & Treasurer at Anasazi Capital Corp. in 2009; President at First Data Card Solutions, Inc. from 1995 to 1997; and Manager-National Sales at Chase Merchant Services LLC from 1979 to 1982. Education includes undergraduate studies at Ithaca College and the University of Western Kentucky.
Kristen L. Gil
Kristen L. Gil is currently an Independent Director at UnitedHealth Group, Inc., a Vice President-Finance Business at Google LLC, and an Advisor at CapitalG Management Company LLC. Previously, she served as an Independent Director at Proofpoint, Inc. from 2017 to 2021. She also held the position of General Manager at Marketron International, Inc. and Vice President & Business Finance Officer at Alphabet, Inc. Ms. Gil completed her undergraduate degree at Cornell University and earned an MBA from Harvard Business School.
Charles D. Baker
Charles D. Baker currently works at The Massachusetts Housing Partnership, as Chairman, Oceans Healthcare LLC, as Chairman, UnitedHealth Group, Inc., as Independent Director from 2023, McLean Hospital, Inc., as Trustee, and The National Collegiate Athletic Association, as President. Mr. Baker also formerly worked at Harvard Pilgrim Health Care, Inc., as President & Chief Executive Officer, Atrius Health, Inc., as Chief Executive Officer, The New England Council, Inc., as Chairman from 2008 to 2012, athenahealth, Inc., as Independent Director in 2013, America's Health Insurance Plans, Inc., as Director, General Catalyst LLC, as Entrepreneur-in-Residence, Health & Human Services Agency Data Center, as Secretary, Bunker Hill Management LLC, as Operating Executive, and State of Massachusetts, as Governor from 2015 to 2023. Mr. Baker received his undergraduate degree from Harvard University and Masters Business Admin degree from Northwestern University.
Scott Gottlieb
Scott Gottlieb is Independent Chairman at Illumina, Inc. starting 2025. Independent Director at Pfizer Inc. since 2019. Director at Wesleyan University, The Mount Sinai Health System, Inc., The Mount Sinai Medical Center, Inc., National Resilience, Inc., Comanche Biopharma Corp. since 2023, Xaira Therapeutics, Inc. since 2024. Independent Director at Tempus AI, Inc. since 2019. Director at Aetion, Inc. since 2019. Independent Director at UnitedHealth Group, Inc. starting 2025. Special Partner at NEA Management Co. LLC since 2019. Partner at New Enterprise Associates, Inc. since 2019. Member of the National Academy of Medicine (United States). Formerly Independent Director at CombiMatrix Corp. from 2009 to 2016. Managing Director at T.R. Winston & Co. LLC from 2013 to 2017. Independent Member of the Board of Directors at Bravo Health, Inc. from 2009 to 2011. Member of the Board of Directors at MedAvante, Inc. from 2007 to 2017. Independent Member of the Board of Directors at Molecular Insight Pharmaceuticals, Inc. from 2007 to 2010. Director at Aseko, Inc. and Targeted Medical Pharma, Inc. Director at EMI Holding, Inc. in 2015. Independent Member of the Board of Directors at American Pathology Partners, Inc. from 2012 to 2017. Member of the Board of Directors at Gradalis, Inc. from 2015 to 2017. Director at Tolero Pharmaceuticals, Inc. from 2015 to 2016. Independent Member of the Board of Directors at Daiichi Sankyo, Inc. from 2015 to 2017. Member of the Board of Directors at Aptiv Solutions, Inc. from 2012 to 2014. Analyst at Alex. Brown & Sons, Inc. from 1994 to 1995. Senior Adviser to the Administrator at Centers for Medicare & Medicaid Services (US). Deputy Commissioner-Medical & Scientific Affairs at US Food & Drug Administration from 2005 to 2007. Commissioner at US Food & Drug Administration from 2017 to 2019. Education includes undergraduate degree from Wesleyan University and doctorate from Icahn School of Medicine at Mount Sinai.